Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs Corticosteroid for Sacroiliac Joint Pain
NCT06081101Phase 1Recruiting
- Sponsor
- McMaster University
- Start
- Mar 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ketorolac in sacroiliac joint dysfunction (2 arms), sponsored by McMaster University. Primary endpoint: Sacroiliac joint pain at 3 months. Started Mar 2025; status: recruiting.
02
Drugs
ketorolac
03
Conditions
sacroiliac joint dysfunction
Beyond the preview
Go deeper on NCT06081101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081101.